Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Passeri

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
JACC. Heart Failure|March 14, 2014
Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathyYuichi J Shimada, Jonathan J Passeri, Aaron L Baggish, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 9, 2009
sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock modelsEmmanuel S Buys, Anje Cauwels, Michael J Raher, et al.
Journal of the American Heart Association|April 13, 2016
Metabolite Profiles Predict Acute Kidney Injury and Mortality in Patients Undergoing Transcatheter Aortic Valve ReplacementSammy Elmariah, Laurie A Farrell, Maureen Daher, et al.
Circulation. Cardiovascular Interventions|November 14, 2013
Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A)Sammy Elmariah, Igor F Palacios, Thomas McAndrew, et al.
Science Translational Medicine|September 13, 2019
Ventricular stroke work and vascular impedance refine the characterization of patients with aortic stenosisEyal Ben-Assa, Jonathan Brown, Zahra Keshavarz-Motamed, et al.
Heart (British Cardiac Society)|January 15, 2015
Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EFJonathan J Passeri, Sammy Elmariah, Ke Xu, et al.
Journal of the American Heart Association|May 27, 2022
Patient- and Process-Related Contributors to the Underuse of Aortic Valve Replacement and Subsequent Mortality in Ambulatory Patients With Severe Aortic StenosisLaura Flannery, Muhammad Etiwy, Alexander Camacho, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 10, 2007
Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overloadEmmanuel S Buys, Michael J Raher, Sarah L Blake, et al.
JAMA Cardiology|November 21, 2019
Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve RepairRasha Al-Bawardy, Sreekanth Vemulapalli, Vinod H Thourani, et al.
The American Journal of Cardiology|December 18, 2021
Relation of Subacute Kidney Injury to Mortality After Transcatheter Aortic Valve ImplantationRicardo Cigarroa, Ayman W Shaqdan, Vaiibhav Patel, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
JACC. Heart Failure|March 14, 2014
Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathyYuichi J Shimada, Jonathan J Passeri, Aaron L Baggish, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 9, 2009
sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock modelsEmmanuel S Buys, Anje Cauwels, Michael J Raher, et al.
Journal of the American Heart Association|April 13, 2016
Metabolite Profiles Predict Acute Kidney Injury and Mortality in Patients Undergoing Transcatheter Aortic Valve ReplacementSammy Elmariah, Laurie A Farrell, Maureen Daher, et al.
Circulation. Cardiovascular Interventions|November 14, 2013
Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A)Sammy Elmariah, Igor F Palacios, Thomas McAndrew, et al.
Science Translational Medicine|September 13, 2019
Ventricular stroke work and vascular impedance refine the characterization of patients with aortic stenosisEyal Ben-Assa, Jonathan Brown, Zahra Keshavarz-Motamed, et al.
Heart (British Cardiac Society)|January 15, 2015
Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EFJonathan J Passeri, Sammy Elmariah, Ke Xu, et al.
Journal of the American Heart Association|May 27, 2022
Patient- and Process-Related Contributors to the Underuse of Aortic Valve Replacement and Subsequent Mortality in Ambulatory Patients With Severe Aortic StenosisLaura Flannery, Muhammad Etiwy, Alexander Camacho, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 10, 2007
Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overloadEmmanuel S Buys, Michael J Raher, Sarah L Blake, et al.
JAMA Cardiology|November 21, 2019
Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve RepairRasha Al-Bawardy, Sreekanth Vemulapalli, Vinod H Thourani, et al.
The American Journal of Cardiology|December 18, 2021
Relation of Subacute Kidney Injury to Mortality After Transcatheter Aortic Valve ImplantationRicardo Cigarroa, Ayman W Shaqdan, Vaiibhav Patel, et al.
Pageof 5